Johnson & Johnson’s Q1 sales were $17.4 billion, a decrease of 4.1% compared to the first quarter of 2014. Operational results increased 3.1% and the negative impact of currency was 7.2%. Domestic sales increased 5.9% while international sales decreased 12.4%, reflecting operational growth of 0.8% and a negative currency impact of 13.2%, the company said. Excluding the net impact of acquisitions and divestitures, on an operational basis, worldwide sales increased 5.7%, domestic sales incre...